Topic

Somatuline Depot (lanreotide)

A collection of 29 issues

Getting Somatuline Depot (Lanreotide) Covered by UnitedHealthcare in California: Complete Prior Authorization and Billing Guide

Answer Box: Your Path to Coverage Getting Somatuline Depot (lanreotide) covered by UnitedHealthcare in California requires prior authorization through OptumRx. Start with proper medical coding: ICD-10 E22.0 for acromegaly or appropriate NET codes, HCPCS J1930 (1 mg per unit), and correct NDCs. UnitedHealthcare often requires step therapy with octreotide

How Long Does It Take to Get Somatuline Depot (lanreotide) Approved by Blue Cross Blue Shield in Virginia? Complete Timeline & Appeals Guide

Answer Box: Getting Somatuline Depot (lanreotide) approved by Blue Cross Blue Shield in Virginia typically takes 5-10 business days for standard prior authorization, or 72 hours for expedited cases. Your fastest path: Have your endocrinologist/oncologist submit complete documentation including diagnosis confirmation, prior octreotide trial details, and medical necessity justification

How to Get Somatuline Depot (lanreotide) Covered by Blue Cross Blue Shield in Ohio: Prior Authorization Forms, Appeals, and Timeline Guide

Answer Box: Getting Somatuline Depot Covered in Ohio Blue Cross Blue Shield (BCBS) plans in Ohio typically require prior authorization for Somatuline Depot (lanreotide) with specific criteria for acromegaly, GEP-NETs, and carcinoid syndrome. Most plans limit coverage to one syringe per 28 days (maximum 120 mg every 4 weeks) and

How to Get Somatuline Depot (Lanreotide) Covered by Humana in New York: Prior Authorization, Appeals, and Cost Assistance Guide

Answer Box: Getting Somatuline Depot Covered by Humana in New York Fastest path to approval: Submit Humana's prior authorization form with diagnosis (acromegaly, GEP-NET, or carcinoid syndrome), prior therapy documentation, and clinical justification. Humana typically covers Somatuline Depot on specialty tier with PA required. If denied, you have

How to Get Somatuline Depot (Lanreotide) Covered by Cigna in New York: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Somatuline Depot Covered by Cigna in New York Eligibility: Somatuline Depot requires prior authorization from Cigna for acromegaly, gastroenteropancreatic neuroendocrine tumors (GEP-NET), and carcinoid syndrome. Fastest approval path: Have your endocrinologist or oncologist submit a complete PA request through Express Scripts' electronic system with documented octreotide

How to Get Somatuline Depot (Lanreotide) Covered by Aetna CVS Health in Florida: Complete Prior Authorization Guide

Answer Box: Getting Somatuline Depot Covered by Aetna CVS Health in Florida Fastest path to approval: Submit Aetna's Somatuline Depot Precertification Request form (GR-69561) with complete clinical documentation showing medical necessity for acromegaly, GEP-NETs, or carcinoid syndrome. Use the Availity provider portal for fastest processing (72-hour decisions vs.

Renewing Somatuline Depot (Lanreotide) Approval with Cigna in Georgia: Complete Timeline and Documentation Guide

Answer Box: Renewing Your Somatuline Depot Coverage Cigna requires annual prior authorization (PA) renewal for Somatuline Depot (lanreotide) in Georgia. Start the renewal process 30-60 days before your current PA expires to avoid treatment gaps. You'll need updated clinical documentation showing continued medical necessity, treatment response, and ongoing

Complete Guide to Getting Somatuline Depot (Lanreotide) Covered by Cigna in Florida: Prior Authorization, Appeals, and Requirements Checklist

Answer Box: Get Somatuline Depot Covered by Cigna in Florida Fastest path to approval: Submit prior authorization through CoverMyMeds with documented octreotide trial failure, specialist letter, and complete clinical notes. Cigna requires step therapy (octreotide first) and Accredo specialty pharmacy for ongoing fills. First step today: Have your endocrinologist or

Work With Your Doctor to Get Somatuline Depot (Lanreotide) Approved by Blue Cross Blue Shield in Michigan: Forms, Appeals, and Success Strategies

Answer Box: Getting Somatuline Depot Covered in Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Somatuline Depot (lanreotide). Approval depends on FDA-approved diagnosis (acromegaly, neuroendocrine tumors, carcinoid syndrome), documented failure of octreotide, and complete clinical documentation. First step: Have your endocrinologist or oncologist gather your treatment history

Somatuline Depot (lanreotide) Approval with UnitedHealthcare in Illinois: Complete Guide to Prior Authorization, Appeals, and Forms

Answer Box: Somatuline Depot (lanreotide) is covered by UnitedHealthcare in Illinois but requires prior authorization, specialist consultation (endocrinologist/oncologist), and documented trial/failure of octreotide in most cases. Submit through the UnitedHealthcare Provider Portal for fastest processing (3-5 business days). If denied, you have 180 days to appeal internally, then